Results 21 to 30 of about 186,102 (296)

Editorial—Current Insights on Lipid-Based Nanosystems

open access: yesPharmaceuticals, 2022
Lipid-based nanosystems, including solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), cationic lipid nanoparticles, nanoemulsions and liposomes, have been extensively studied to improve drug delivery through different administration
Ana Catarina Silva   +2 more
doaj   +1 more source

Lipid Polymeric Hybrid Nanoparticles: Formulation Techniques and Effects on Glioblastoma [PDF]

open access: yesPharmaceutical Sciences, 2022
In the pharmaceutical industry, liposomes and polymeric nanoparticles are the two most commonly studied delivery vehicles. A new technique uses lipid-polymeric hybrid nanoparticles (LPHNPs) with a polymeric core, and a shell made up of lipid-lipid-PEG ...
Yudhishtir Singh Baghel   +1 more
doaj   +1 more source

Lipid Nanoparticles Based Cosmetics with Potential Application in Alleviating Skin Disorders

open access: yesCosmetics, 2021
The lipids mainly oils, fats, waxes and phospholipids are of substantial importance in the development and functioning of cosmetic products. The lipid nanoparticles-based cosmetic product is highly capable of protecting the skin against harmful ...
Javed Ahmad
doaj   +1 more source

Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines

open access: yesVaccines, 2021
COVID-19 vaccines have been developed with unprecedented speed which would not have been possible without decades of fundamental research on delivery nanotechnology.
Thai Thanh Hoang Thi   +5 more
doaj   +1 more source

Recent advancements in the targeted delivery of Gemcitabine: Harnessing nanomedicine for enhanced cancer therapy

open access: yesOpenNano, 2023
Gemcitabine (GEM) is a chemotherapeutic drug widely used for treating pancreatic cancer and other cancers. Despite its efficacy, GEM is associated with adverse side effects and tumor resistance, hampering its therapeutic outcomes.
Mehrab Pourmadadi   +7 more
doaj   +1 more source

Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications

open access: yesPharmaceutical Fronts, 2022
Lipid-based nanocarriers have been extensively investigated for drug delivery due to their advantages including biodegradability, biocompatibility, nontoxicity, and nonimmunogenicity. However, the shortcomings of traditional lipid-based nanocarriers such
Yan-Qi Zhao   +6 more
doaj   +1 more source

Phase‐Separated Lipid‐Based Nanoparticles: Selective Behavior at the Nano‐Bio Interface

open access: yesAdvanced Materials, 2023
AbstractThe membrane‐protein interface on lipid‐based nanoparticles influences their in vivo behavior. Better understanding may evolve current drug delivery methods toward effective targeted nanomedicine. Previously, the cell‐selective accumulation of a liposome formulation in vivo is demonstrated, through the recognition of lipid phase‐separation by ...
Papadopoulou, P.   +15 more
openaire   +6 more sources

Microfluidic Devices for Precision Nanoparticle Production

open access: yesMicro, 2023
In recent years, the field of drug delivery has seen a significant shift towards the exploration and utilization of nanoparticles (NPs) as versatile carriers for therapeutic agents.
Ayşenur Bezelya   +2 more
doaj   +1 more source

A saposin-lipoprotein nanoparticle system for membrane proteins. [PDF]

open access: yes, 2016
A limiting factor in membrane protein research is the ability to solubilize and stabilize such proteins. Detergents are used most often for solubilizing membrane proteins, but they are associated with protein instability and poor compatibility with ...
Armache, Jean-Paul   +13 more
core   +2 more sources

Hybrid plasmonic photoreactors as visible light-mediated bactericides [PDF]

open access: yes, 2020
Photocatalytic compounds and complexes, such as tris(bipyridine)ruthenium(II), [Ru(bpy)3]2+, have recently attracted attention as light-mediated bactericides that can help to address the need for new antibacterial strategies.
An, Xingda   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy